Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Zobrazit další vydání (1)

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

Podrobná bibliografie
Hlavní autoři:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
Médium:	Journal article
Jazyk:	English
Vydáno:	2012

Podobné jednotky

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
Autor: Gillies, R, a další
Vydáno: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
Autor: Findlay, J, a další
Vydáno: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
Autor: Gillies, R, a další
Vydáno: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
Autor: Gillies, R, a další
Vydáno: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
Autor: Findlay, J, a další
Vydáno: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
Autor: Gillies, R, a další
Vydáno: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Autor: Gillies, R, a další
Vydáno: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
Autor: Gillies, R, a další
Vydáno: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
Autor: Findlay, J, a další
Vydáno: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
Autor: Teoh, S, a další
Vydáno: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
Autor: Chowdhury, F, a další
Vydáno: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
Autor: Millo, J, a další
Vydáno: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Autor: Findlay, J, a další
Vydáno: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
Autor: Rana, M, a další
Vydáno: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
Autor: den Boer, RB, a další
Vydáno: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Autor: John M. Findlay, a další
Vydáno: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
Autor: Gillies, R, a další
Vydáno: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
Autor: Kieran G. Foley, a další
Vydáno: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
Autor: Teoh, S, a další
Vydáno: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
Autor: Reem Yusuf AlBuainain, a další
Vydáno: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
Autor: Tarik Sengoz, a další
Vydáno: (2023-04-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
Autor: Chowdhury, F, a další
Vydáno: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
Autor: A. G. M. T. Powell, a další
Vydáno: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
Autor: Alexander M Th Schmitz, a další
Vydáno: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
Autor: Lihua Chen, a další
Vydáno: (2017-08-01)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
Autor: Turkington, RC, a další
Vydáno: (2019)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
Autor: Findlay, J, a další
Vydáno: (2019)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
Autor: Sun-pyo Hong, a další
Vydáno: (2024-10-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
Autor: M. K. Ibragimova, a další
Vydáno: (2022-03-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
Autor: Sangwon Han, a další
Vydáno: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
Autor: Narendra Pandit, a další
Vydáno: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
Autor: Inci Kizildag Yirgin, a další
Vydáno: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
Autor: Yao J, a další
Vydáno: (2021-10-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
Autor: M. K. Ibragimova, a další
Vydáno: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
Autor: Rui-Qin Zhou, a další
Vydáno: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
Autor: Giulia Polverari, a další
Vydáno: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
Autor: LU Shengnan, a další
Vydáno: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
Autor: Willard Wong, a další
Vydáno: (2021-07-01)

EVALUATİON OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY İN PATİENTS WİTH BREAST CANCER
Autor: Can Atalay, a další
Vydáno: (2007-01-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
Autor: P. V. Kazantseva, a další
Vydáno: (2016-07-01)